Dr. Jonghwa Lee is a postdoctoral research associate in the Division of Pharmacotherapy and Experimental Therapeutics in the laboratory of Dr. Klarissa Jackson at UNC Eshelman School of Pharmacy. Dr. Lee obtained his bachelor’s degree in chemistry from the University of Western Ontario, Canada. He then obtained his MSc in pharmacology and Ph.D. in biochemistry/molecular biology from Dalhousie University, Canada. His current research focuses on characterizing the metabolism of venetoclax, a selective BCL-2 inhibitor used to treat chronic lymphocytic leukemia. He is also interested in identifying endogenous biomarkers that can be used to quantify CYP3A activity and predict individual venetoclax metabolism/toxicity.